Origami Surgical
Private Company
Total funding raised: $17.5M
Overview
Origami Surgical is a private, commercial-stage medical device company addressing a critical safety and efficiency gap in the rapidly growing robotic surgery market. Its flagship product, StitchKit, is a suture-needle management device that secures needles during transfer into the surgical field, directly tackling the problem of lost surgical sharps (needles), which are considered 'never events' but still occur with significant clinical and financial consequences. With a seasoned leadership team and published clinical evidence supporting its value proposition, the company is positioned to capture market share by improving OR workflow and reducing hospital costs associated with retained surgical items.
Technology Platform
StitchKit: a single-use suture-needle management device for securing and transferring needles in robotic and laparoscopic surgery, eliminating exposed needle hand-offs.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
The direct competitive landscape for dedicated needle-transfer safety devices in robotic surgery appears nascent, giving Origami Surgical a potential first-mover advantage. However, it competes indirectly with the status quo (exposed manual transfer) and faces potential future competition from large robotic platform companies (e.g., Intuitive Surgical) and broad-line surgical device giants (e.g., Medtronic, J&J) that could integrate similar features.